The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Postmenopausal Hormone Therapy and Change in Mammographic Density
Abstract
BACKGROUND: Mammographic density is an independent risk factor for breast cancer. Postmenopausal hormone use is associated with an increase in mammographic density, but the magnitude of the density increase is unknown. METHODS: Baseline and 12-month mammograms were obtained for 571 (65%) of the 875 women, aged 45-64 years, who were enrolled in the Postmenopausal Estrogen/Progestin Interventions Trial and randomly assigned to receive placebo, daily conjugated equine estrogens at 0.625 mg/day (CEE), daily CEE and medroxyprogesterone acetate (MPA) at 10 mg/day on days 1-12 (CEE+MPA-cyclic), daily CEE and MPA at 2.5 mg/day (CEE+MPA-continuous), or daily CEE and micronized progesterone (MP) at 200 mg/day on days 1-12 (CEE+MP). We analyzed digitized mammograms to determine the percentage of the left breast that was composed of dense tissue (i.e., mammographic percent density). Linear regression analysis was used to examine the effects of treatments on the change in mammographic percent density between baseline and 12 months, before and after adjustment for possible confounders. All statistical tests were two-sided. RESULTS: The adjusted absolute mean changes in mammographic percent density over 12 months were 4.76% (95% confidence interval [CI] = 3.29% to 6.23%), 4.58% (95% CI = 3.19% to 5.97%), and 3.08% (95% CI = 1.65% to 4.51%) for women in the CEE+MPA-cyclic, CEE+MPA-continuous, and CEE-MP groups, respectively. Each of those absolute mean changes was statistically significantly different from the adjusted absolute mean change in mammographic percent density for women in the placebo group, which was -0.07% (95% CI = -1.50% to 1.38%). CONCLUSION: Greater mammographic density was associated with the use of estrogen/progestin combination therapy, regardless of how the progestin was given, but not with the use of estrogen only.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Valery (1995) · doi:10.1001/jama.1995.03520270033028 · Cited by 2,320
Detection of Influential Observation in Linear Regression
Cook, R. D. (2000) · Technometrics · doi:10.2307/1271434 · Cited by 2,269
A DATA-BASED APPROACH TO DIET QUESTIONNAIRE DESIGN AND TESTING
BLOCK, G., HARTMAN, A. M., DRESSER, C. M., CARROLL, M. D., GANNON, J., & GARDNER, L. (1986) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114416 · Cited by 2,163
Breast imaging reporting and data system (BI-RADS)
Liberman, L., & Menell, J. H. (2002) · Radiologic Clinics of North America · doi:10.1016/s0033-8389(01)00017-3 · Cited by 2,155
Berg, W. A., Campassi, C., Langenberg, P., & Sexton, M. J. (2000) · American Journal of Roentgenology · doi:10.2214/ajr.174.6.1741769 · Cited by 1,273
Boyd, N. F., Byng, J. W., Jong, R. A., Fishell, E. K., Little, L. E., Miller, A. B., Lockwood, G. A., Tritchler, D. L., & Yaffe, M. J. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.9.670 · Cited by 1,105
Menopausal Estrogen and Estrogen-Progestin Replacement Therapy and Breast Cancer Risk
Schairer, C. (2000) · JAMA · doi:10.1001/jama.283.4.485 · Cited by 1,048
Detection of Influential Observation in Linear Regression
Cook, R. D. (1977) · Technometrics · doi:10.2307/1268249 · Cited by 978
Breast patterns as an index of risk for developing breast cancer
Wolfe, J. (1976) · American Journal of Roentgenology · doi:10.2214/ajr.126.6.1130 · Cited by 916
Mammographic Features and Breast Cancer Risk: Effects With Time, Age, and Menopause Status
Byrne, C., Schairer, C., Wolfe, J., Parekh, N., Salane, M., Brinton, L. A., Hoover, R., & Haile, R. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.21.1622 · Cited by 864
Mammographic densities and breast cancer risk.
Boyd, N. F., Lockwood, G. A., Byng, J. W., Tritchler, D., & Yaffe, M. J. (1998) · PubMed · Cited by 810
Effects of Estrogen and Estrogen–Progestin on Mammographic Parenchymal Density
Greendale, G. A., Reboussin, B. A., Sie, A., Singh, H. R., Olson, L. K., Gatewood, O., Bassett, L. W., Wasilauskas, C., Bush, T., Barrett-Connor, E., et al. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-4_part_1-199902160-00003 · Cited by 401
Self-citationWolfe, J., Saftlas, A., & Salane, M. (1987) · American Journal of Roentgenology · doi:10.2214/ajr.148.6.1087 · Cited by 277
Rutter, C. M. (2001) · JAMA · doi:10.1001/jama.285.2.171 · Cited by 260
A Case-Control Study of Menopausal Estrogen Therapy and Breast Cancer
Ross, R. K. (1980) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1980.03300420019018 · Cited by 254
Boyd, N. F., Greenberg, C., Lockwood, G., Little, L., Martin, L., Tritchler, D., Byng, J., & Yaffe, M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.7.488 · Cited by 236
Warner, E., Lockwood, G., Tritchler, D., & Boyd, N. F. (1992) · PubMed · Cited by 202
MAMMOGRAPHIC PARENCHYMAL PATTERNS AND BREAST CANCER RISK1
Saftlas, A. F., & Szklo, M. (1987) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036300 · Cited by 187
Persson, I., Thurfjell, E., & Holmberg, L. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.10.3201 · Cited by 187
Symmetry of projection in the quantitative analysis of mammographic images
Byng, J. W., Boyd, N. F., Little, L., Lockwood, G., Fishell, E., Jong, R. A., & Yaffe, M. J. (1996) · European Journal of Cancer Prevention · doi:10.1097/00008469-199610000-00003 · Cited by 159
Mammographic breast density during hormone replacement therapy: Differences according to treatment
Lundström, E., Wilczek, B., von Palffy, Z., Söderqvist, G., & von Schoultz, B. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70560-0 · Cited by 159
The detection of changes in mammographic densities.
Ursin, G., Astrahan, M. A., Salane, M., Parisky, Y. R., Pearce, J. G., Daniels, J. R., Pike, M. C., & SPICER, D. V. (1998) · PubMed · Cited by 147
Self-citationFreedman, M. T., Martin, J. S., O'Gorman, J. T., Eckert, S., Lippman, M. E., Lo, S.-C. B., Walls, E. L., & Zeng, J. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.1.51 · Cited by 143
Mammographic patterns as a predictive biomarker of breast cancer risk: effect of tamoxifen.
Atkinson, C., Warren, R. M. L., Bingham, S. A., & Day, N. E. (1999) · PubMed · Cited by 142
SPICER, D. V., Ursin, G., Parisky, Y. R., Pearce, J. G., Shoupe, D., Pike, A., & Pike, M. C. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.6.431 · Cited by 140
Self-citation[Cancer detection and prevention].
Fujimoto, H., Kawamura, T., Koizumi, F., & ISHIMORI, A. (1991) · PubMed · Cited by 112
Effect of tamoxifen on mammographic density.
Chow, C. K., Venzon, D. J., Jones, E. C., Premkumar, A., O’Shaughnessy, J., & Zujewski, J. A. (2000) · PubMed · Cited by 108
Greendale, G. A., Bodin-Dunn, L., Ingles, S., Haile, R., & Barrett-Connor, E. L. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440040090010 · Cited by 68
Self-citationPike, M. C., Ross, R. K., & SPICER, D. V. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009515 · Cited by 67
Self-citationRationale, Design, and Conduct of the PEPI Trial
Espeland, M. A. (1995) · Controlled Clinical Trials · doi:10.1016/0197-2456(94)00033-y · Cited by 60
Bias in Breast Cancer Analyses Due to Error in Age at Menopause
Rockhill, B., Colditz, G. A., & ROSNER, B. A. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010220 · Cited by 54
Cited by
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Fournier, A., Berrino, F., & Clavel-Chapelon, F. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9523-x · Cited by 693
Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement
Santen, R. J., Allred, D. C., Ardoin, S. P., Archer, D. F., Boyd, N., Braunstein, G. D., Burger, H. G., Colditz, G. A., Davis, S. R., Gambacciani, M., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2509 · Cited by 680
Mammographic breast density as an intermediate phenotype for breast cancer
Boyd, N. F., Rommens, J. M., Vogt, K., Lee, V., Hopper, J. L., Yaffe, M. J., & Paterson, A. D. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70390-9 · Cited by 613
Metadata
- Authors
- Greendale, G. A., Reboussin, B. A., Slone, S., Wasilauskas, C., Pike, M. C., & Ursin, G.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-01-01
- Volume
- 95
- Issue
- 1
- Pages
- 30-37
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W1997655151
- Cited by
- 419
- References
- 31
- FWCI
- 25.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.